Boehringer Ingelheim CEO sees Korea emerging as pharmaceutical innovation hub
AI Summary- Shashank Deshpande said Korea is becoming a source of pharmaceutical innovation.
- Local biotech partnerships and clinical research are expected to support global drug development.
- Deshpande spoke during the 19th Asia-Pacific Conference of German Business in Seoul on Friday.